BamSEC and AlphaSense Join Forces
Learn More

Aura Biosciences Inc.

NASDAQ: AURA    
Share price (12/20/24): $8.20    
Market cap (12/20/24): $410 million

Material Contracts Filter

EX-10.3
from 10-Q 14 pages Aura Biosciences, Inc. Executive Severance Plan 1
12/34/56
EX-10.2
from 10-Q 5 pages September 25, 2024 Personal and Confidential Julie Feder Re: Resignation and Consulting Agreement Dear Ms. Feder
12/34/56
EX-10.1
from 10-Q 10 pages September 25, 2024 Personal and Confidential Julie Feder Re: Transition and Release Agreement Dear Ms. Feder
12/34/56
EX-10.1
from 10-Q 4 pages Aura Biosciences, Inc. Amended and Restated Non-Employee Director Compensation Policy
12/34/56
EX-10.1
from 10-Q 7 pages Salary and Expenses: Your Compensation Will Be a Starting Salary of Four-Hundred and Forty Thousand ($440,000.00) Dollars Per Annum Subject to Any Company Discretionary Increase, (The “Base Salary”), Which Will Be Paid Bi-Weekly or in Accordance With the Company’s Normal Payroll Practices in Effect From Time to Time. in Accordance With Company Policies and Procedures, You Will Be Reimbursed for All Reasonable Out-Of-Pocket Expenses Incurred by You on Behalf of the Company, in Accordance With Company Policy. 2. Annual Bonuses
12/34/56
EX-10.17
from 10-K 7 pages Salary and Expenses: Your Compensation Will Be a Starting Salary of Four-Hundred and Fifty-Five Thousand ($455,000.00) Dollars Per Annum Subject to Any Company Discretionary Increase, (The “Base Salary”), Which Will Be Paid Bi-Weekly or in Accordance With the Company’s Normal Payroll Practices in Effect From Time to Time. in Accordance With Company Policies and Procedures, You Will Be Reimbursed for All Reasonable Out-Of-Pocket Expenses Incurred by You on Behalf of the Company, in Accordance With Company Policy. 2. Annual Bonuses
12/34/56
EX-10.4
from 10-Q 10 pages Personal and Confidential Dr. Cadmus Rich Re: Transition and Release Agreement • the Company Shall Pay You Salary, Any Accrued but Unused Vacation, and Unpaid and Properly Documented Business Expenses Accrued to You Through the Last Day of Your Employment
12/34/56
EX-10.3
from 10-Q 5 pages Personal and Confidential Dr. Cadmus Rich Re: Resignation and Consulting Agreement
12/34/56
EX-10.2
from 10-Q 9 pages September 26, 2023 Personal and Confidential Dr. Cadmus Rich Re: Transition and Release Agreement • the Company Shall Pay You Salary, Any Accrued but Unused Vacation, and Unpaid and Properly Documented Business Expenses Accrued to You Through the Last Day of Your Employment
12/34/56
EX-10.1
from 10-Q 7 pages August 8, 2023 2. Bonuses
12/34/56
EX-10.1
from 10-Q 184 pages Lease Between Aura Biosciences, Inc., as Tenant and Ice Box, LLC, as Landlord 80 Guest Street, Brighton, Ma
12/34/56
EX-10.1
from S-8 42 pages Aura Biosciences, Inc. 2021 Stock Option and Incentive Plan
12/34/56
EX-10.10
from S-1/A 10 pages 4. Annual Bonus. You Will Be Eligible to Receive an Annual Bonus Targeted at 35% of Your Base Salary Based on the Performance of the Company (The “Bonus”). the Amount of the Bonus, if Any, Will Be at the Sole Discretion of the Company. You Must Be Employed on the Date That the Bonus Is Paid in Order to Be Eligible to Receive the Bonus
12/34/56
EX-10.9
from S-1/A 10 pages August 9, 2018 Julie B. Feder 85 Somerset Rd. Brookline, Ma 02445 Re: Offer of Employment Dear Julie: Following Up on Our Discussions, the Following Represents Our Offer Regarding Your Employment by Aura Biosciences, Inc. (The “Company”) as an “At Will” Employee
12/34/56
EX-10.8
from S-1/A 19 pages 22 January 2010 One Broadway 14th Floor Cambridge 02142 Ma Re: Offer of Employment Dear Elisabet
12/34/56
EX-10.7
from S-1/A 34 pages Aura Biosciences, Inc. Form of Director Indemnification Agreement
12/34/56
EX-10.6
from S-1/A 3 pages Aura Biosciences, Inc. Senior Executive Cash Incentive Bonus Plan
12/34/56
EX-10.5
from S-1/A 2 pages Aura Biosciences, Inc. Non-Employee Director Compensation Policy
12/34/56
EX-10.4
from S-1/A 12 pages Aura Biosciences, Inc. 2021 Employee Stock Purchase Plan
12/34/56
EX-10.3
from S-1/A 17 pages Aura Biosciences, Inc. 2021 Stock Option and Incentive Plan
12/34/56